To achieve this, we designed ASOs to deliberately disrupt proper splice site recognition required for the removal of intron 13, thereby inducing its inclusion in GTF2H4 mRNA transcripts and mimicking the XP-J patient’s frameshift pathogenic mutation located in its exon 13 (Figure 4A and Table 1). Here, GTF2H4 is linked to xeroderma pigmentosum.